The FDA has announced a voluntary recall of Clear Eyes Maximum Itchy Eye Relief eye drops due to concerns about possible contamination. Consumers are urged to check their medicine cabinets and avoid using the product while the recall is underway.
- Recall affects 39,060 bottles nationwide
- Potential contamination leads to sterility concerns
- Consumers advised to discontinue use and seek refunds
What happened
Prestige Brand Holdings voluntarily recalled nearly 40,000 bottles of Clear Eyes Maximum Itchy Eye Relief on July 29, following concerns about the product's sterility. The recall was updated to a Class II classification by the FDA on August 14, signaling a moderate risk that could cause temporary and treatable medical issues, but no serious harm.
The affected eye drops come in 15 mL bottles with lot code 2552 and an expiration date of September 30, 2027. They were distributed nationwide by Medtech Products, Inc., and are sold through many common retailers including CVS, Walgreens, Amazon, and Target. Consumers should carefully check their bottles for these details.
Why it feels good
Recalls like this one, though inconvenient, highlight the effectiveness of safety oversight in consumer health products. The fact that this recall is voluntary and the FDA’s transparent communication offer reassurance that consumer wellness is a top priority.
Knowing that the recalled eye drops are unlikely to cause serious damage if used before the recall was issued helps ease concerns. The prompt alert and clear guidelines empower consumers to take simple actions like discontinuing use and obtaining refunds, preventing potential discomfort without panic.
What to enjoy or watch next
If you are looking for relief from itchy eyes while the recall is in effect, consider consulting your pharmacist about alternative products that are verified safe and effective. Pharmacists can provide personalized advice suited to your needs and health conditions.
Stay updated on this recall and other consumer health news by regularly checking FDA announcements and reputable health resources. Reporting any adverse effects through the FDA’s MedWatch program can also help authorities maintain product safety for everyone.